Oleksandr Narykov

Dr. Oleksandr Narykov

DSL, Argonne National Laboratory, Lemont, Illinois, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2020 in Viruses
Verified
Journal Article
Open access
PDF file
SSSuhas Srinivasan
Suhas Srinivasan
HCHongzhu Cui
Hongzhu Cui
ZGZiyang Gao
Ziyang Gao
MLMing Liu
Ming Liu
SLSenbao Lu
Senbao Lu
DKDmitry Korkin
Dmitry Korkin
During its first two and a half months, the recently emerged 2019 novel coronavirus, SARS-CoV-2, has already infected over one-hundred thousand people worldwide and has taken more than four thousand lives. However, the swiftly spreading virus also caused an unprecedentedly rapid response from the research community facing the unknown health challenge of potentially enormous proportions. Unfortunately, the experimental research to understand the molecular mechanisms behind the viral infection and to design a vaccine or antivirals is costly and takes months to develop. To expedite the advancement of our knowledge, we leveraged data about the related coronaviruses that is readily available in public databases and integrated these data into a single computational pipeline. As a result, we provide comprehensive structural genomics and interactomics roadmaps of SARS-CoV-2 and use this information to infer the possible functional differences and similarities with the related SARS coronavirus. All data are made publicly available to the research community.

6 January 2025 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
ASAkshat Singhal
Akshat Singhal
XZXiaoyu Zhao
Xiaoyu Zhao
PWPatrick Wall
Patrick Wall
ESEmily So
Emily So
GCGuido Calderini
Guido Calderini
TITrey Ideker
Trey Ideker
The rapid evolution of machine learning has led to a proliferation of sophisticated models for predicting therapeutic responses in cancer. While many of these show promise in research, standards for clinical evaluation and adoption are lacking. Here, we propose seven hallmarks by which predictive oncology models can be assessed and compared. These are Data Relevance and Actionability, Expressive Architecture, Standardized Benchmarking, Generalizability, Interpretability, Accessibility and Reproducibility, and Fairness. Considerations for each hallmark are discussed along with an example model scorecard. We encourage the broader community, including researchers, clinicians, and regulators, to engage in shaping these guidelines toward a concise set of standards. Significance: As the field of artificial intelligence evolves rapidly, these hallmarks are intended to capture fundamental, complementary concepts necessary for the progress and timely adoption of predictive modeling in precision oncology. Through these hallmarks, we hope to establish standards and guidelines that enable the symbiotic development of artificial intelligence and precision oncology.

7 May 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
ONOleksandr Narykov
Oleksandr Narykov
SSSuhas Srinivasan
Suhas Srinivasan
DKDmitry Korkin
Dmitry Korkin

26 January 2024 in Cancers
Verified
Journal Article
Open access
PDF file
PVPriyanka Vasanthakumari
Priyanka Vasanthakumari
YZYitan Zhu
Yitan Zhu
TBThomas Brettin
Thomas Brettin
APAlexander Partin
Alexander Partin
MSMaulik Shukla
Maulik Shukla
RSRick L. Stevens
Rick L. Stevens
It is well-known that cancers of the same histology type can respond differently to a treatment. Thus, computational drug response prediction is of paramount importance for both preclinical drug screening studies and clinical treatment design. To build drug response prediction models, treatment response data need to be generated through screening experiments and used as input to train the prediction models. In this study, we investigate various active learning strategies of selecting experiments to generate response data for the purposes of (1) improving the performance of drug response prediction models built on the data and (2) identifying effective treatments. Here, we focus on constructing drug-specific response prediction models for cancer cell lines. Various approaches have been designed and applied to select cell lines for screening, including a random, greedy, uncertainty, diversity, combination of greedy and uncertainty, sampling-based hybrid, and iteration-based hybrid approach. All of these approaches are evaluated and compared using two criteria: (1) the number of identified hits that are selected experiments validated to be responsive, and (2) the performance of the response prediction model trained on the data of selected experiments. The analysis was conducted for 57 drugs and the results show a significant improvement on identifying hits using active learning approaches compared with the random and greedy sampling method. Active learning approaches also show an improvement on response prediction performance for some of the drugs and analysis runs compared with the greedy sampling method.

15 September 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
WPWeria Pezeshkian
Weria Pezeshkian
FGFabian Grünewald
Fabian Grünewald
ONOleksandr Narykov
Oleksandr Narykov
SLSenbao Lu
Senbao Lu
VAValeria Arkhipova
Valeria Arkhipova
DKDmitry Korkin
Dmitry Korkin
Despite tremendous efforts by the research community during the COVID-19 pandemic, the exact structure of SARS-CoV-2 and related betacoronaviruses remains elusive. Being a key structural component of the SARS-CoV-2 virion, the envelope encapsulates viral RNA and is composed of three structural proteins, spike (S), membrane (M), and envelope (E), which interact with each other and with the lipids acquired from the host membranes. Here, we developed and applied an integrative multiscale computational approach to model the envelope structure of SARS-CoV-2 with near atomistic detail, focusing on studying the dynamic nature and molecular interactions of its most abundant, but largely understudied, M protein. The molecular dynamics simulations allowed us to test the envelope stability under different configurations and revealed that the M dimers agglomerated into large, filament-like, macromolecular assemblies with distinct molecular patterns formed by M’s transmembrane and intravirion (endo) domains. These results are in good agreement with current experimental data, demonstrating a generic and versatile integrative approach to model the structure of a virus de novo . We anticipate our work to provide insights into critical roles of structural proteins in the viral assembly and integration, proposing new targets for the antiviral therapies.

27 July 2019 in Bioinformatics
Verified
Journal Article
Open access
PDF file
ONOleksandr Narykov
Oleksandr Narykov
DBDmytro Bogatov
Dmytro Bogatov
DKDmitry Korkin
Dmitry Korkin
The complexity of protein–protein interactions (PPIs) is further compounded by the fact that an average protein consists of two or more domains, structurally and evolutionary independent subunits. Experimental studies have demonstrated that an interaction between a pair of proteins is not carried out by all domains constituting each protein, but rather by a select subset. However, determining which domains from each protein mediate the corresponding PPI is a challenging task. Here, we present domain interaction statistical potential (DISPOT), a simple knowledge-based statistical potential that estimates the propensity of an interaction between a pair of protein domains, given their structural classification of protein (SCOP) family annotations. The statistical potential is derived based on the analysis of >352 000 structurally resolved PPIs obtained from DOMMINO, a comprehensive database of structurally resolved macromolecular interactions. DISPOT is implemented in Python 2.7 and packaged as an open-source tool. DISPOT is implemented in two modes, basic and auto-extraction. The source code for both modes is available on GitHub: https://github.com/korkinlab/dispot and standalone docker images on DockerHub: https://hub.docker.com/r/korkinlab/dispot. The web server is freely available at http://dispot.korkinlab.org/. Supplementary data are available at Bioinformatics online.